Management of Allogeneic Stem Cell Transplantation for High-Risk AML following SARS-CoV-2 Associated Pancytopenia with Marked Bone Marrow Biopsy Alterations

Management of Allogeneic Stem Cell Transplantation for High-Risk AML following SARS-CoV-2 Associated Pancytopenia with Marked Bone Marrow Biopsy Alterations

The present study describes a patient aged 70 with very high-risk AML who successfully received a nonmyeloablative matched unrelated donor allograft shortly following SARS-CoV-2 infection, which manifested with mild cough, interstitial abnormalities on chest CT, and pancytopenia with profound bone m...

Full description

Bibliographic Details
Main Authors: Maria Kaparou, Zbigniew Rudzki, Hannah Giles, Vidhya Murthy, Swathy Srinath, Rebecca Lloyd, Maria Zahid Ahmed, Beena Salhan, Saleena Chauhan, Bhuvan Kishore, Richard Lovell, Claire Horgan, Shankara Paneesha, Evgenia Xenou, Anand Lokare, Joanne Ewing, Hansini Dassanayake, Emmanouil Nikolousis, Alexandros Kanellopoulos
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2021/8843063

Internet

http://dx.doi.org/10.1155/2021/8843063

Similar Items